不同剂量131I清甲治疗对分化型甲状腺癌唾液腺功能和生活质量的影响

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

不同剂量131I清甲治疗对分化型甲状腺癌唾液腺功能和生活
质量的影响
李欢;杜小梅;冯真;冯靖雄
【期刊名称】《解放军医药杂志》
【年(卷),期】2017(029)010
【摘要】目的探讨不同剂量131 I清甲治疗对分化型甲状腺癌(DTC)术后唾液腺功能和生活质量的影响.方法对四川省达州市中心医院2014年1月—2016年1月收治的150例DTC患者的临床资料进行回顾性分析,根据131 I治疗剂量分为A、
B、C组,每组50例.3组均行甲状腺根治术后给予131 I治疗,A组治疗剂量为
1.11~3.7 GBq(30~100 mci),B组治疗剂量为3.7~5.5 GBq(100~150 mci),C组治疗剂量为5.5~7.4 GBq(150~200 mci).观察3组唾液腺定量分析结果,比较治疗前后生活质量评分.结果B组唾液腺功能受损率均低于A、C组,且A组低于C组(P<0.05).治疗后3组生活质量各方面评分均高于治疗前,且B组高于A、C组,A组高于C组(P<0.05).结论DTC术后应用3.7~5.5 GBq(100~150 mci)131I辅助治疗可有效降低唾液腺损伤风险,提高患者生活质量.%Objective To investigate effects of different doses iodine l31 (131I) thyroidectom treatment on sali-vary gland function and life quality of patients with differentiated thyroid carcinoma ( DTC) . Methods Clinical data of 150 patients with DTC admitted during January 2014 and January 2016 was retrospectively analyzed, and the patients were divided into group A, B and C ( n=50 for each group) according to different doses 131 I treatments. 131 I treatments were given for all patients after thyroid radical operation, and
treatment doses were 1. 11-3. 7 GBq (30-100 mci) in group A, 3. 7-5. 5 GBq (100-150 mci) in group B and 5. 5-7. 4 GBq (150 ~200 mci) in group C respectively. Results of sialaden quantitative analysis were observed, and scores of life quality before and after treatment were compare among the three groups. Results Damage rate of salivary gland function in group B was significantly lower than those in group A and C, and the rate in group A was significantly lower than that in group C ( P<0. 05 ) . Scores for all aspects of life quality after treatment were significantly higher than those before treatment in three groups, and the score in group B were significantly higher than those in group A and C, and the score in group A were significantly higher than those in group C (P<0. 05). Conclusion The 8. 25-10. 41GBq 131I in adjunctive treatment of patients with DTC after operation can ef-fectively decrease risk of salivary gland damage and improve life quality.
【总页数】4页(P26-29)
【作者】李欢;杜小梅;冯真;冯靖雄
【作者单位】635000 四川达州,达州市中心医院核医学科;635000 四川达州,达州市中心医院核医学科;635000 四川达州,达州市中心医院核医学科;635000 四川达州,达州市中心医院临床药学科
【正文语种】中文
【中图分类】R736.1
【相关文献】
1.分化型甲状腺癌术后患者首次131I“清甲”治疗后对唾液腺功能的影响 [J], 杨文定;邹劲涛;覃卫华;覃绍超;董经纬
2.99mTcO4-唾液腺动态显像评价131I清甲治疗后分化型甲状腺癌患者的唾液腺功能 [J], 吴菊清;欧阳伟;冯会娟;孙云刚;李师思;陈盼
3.不同剂量131I治疗非高危分化型甲状腺癌对患者唾液腺功能影响的差异 [J], 石飞;高芸;李建;潘奕
4.不同剂量131I清甲治疗对分化型甲状腺癌唾液腺功能和生活质量的影响 [J], 李欢;杜小梅;冯真;冯靖雄;
5.颈淋巴结清除术前不同剂量131I对甲状腺癌患者唾液腺功能和生活质量的影响及作用机制研究 [J], 樊雪缘; 杨绮; 周凡; 廖杰
因版权原因,仅展示原文概要,查看原文内容请购买。

相关文档
最新文档